BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19020376)

  • 1. HypoCCS: a decade of an observational study. Foreword.
    Beck-Peccoz P
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):1. PubMed ID: 19020376
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of current growth hormone treatments and future therapies.
    Ross R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
    Lamberts SW
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth hormone therapy in adults].
    Kann PH
    Internist (Berl); 2005 Sep; 46(9):1047-52. PubMed ID: 15928941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
    Losa M; Gatti E; Rossini A; Lanzi R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety aspects of growth hormone replacement.
    Waterhouse M; Monson JP
    Front Horm Res; 2005; 33():209-221. PubMed ID: 16166764
    [No Abstract]   [Full Text] [Related]  

  • 7. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
    Cannavò S; Marini F; Trimarchi F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversy about treatment of growth hormone-deficient adults: a commentary.
    Frohman LA
    Ann Intern Med; 2002 Aug; 137(3):202-4. PubMed ID: 12160369
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment approaches for growth failure.
    Rosenbloom AL
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):48-50. PubMed ID: 18806725
    [No Abstract]   [Full Text] [Related]  

  • 10. Lies, damn lies and statistics.
    Sonksen PH; McGauley G
    Growth Horm IGF Res; 2005 Jun; 15(3):173-6. PubMed ID: 15878300
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors.
    Faienza MF; Delvecchio M; Indrio F; Francavilla R; Acquafredda A; Cavallo L
    Horm Res; 2009; 71(6):372-5. PubMed ID: 19506396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement therapy and cardiovascular diseases.
    Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of quality of life in patients with growth hormone deficiency.
    Webb SM
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactocele in a male infant with congenital hypopituitarism.
    Rahman N; Davenport M; Buchanan C
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1451-3. PubMed ID: 15526725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of short stature and the response to growth hormone therapy.
    Dunger DB
    Horm Res; 2009 Apr; 71 Suppl 2():2-4. PubMed ID: 19407490
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic implications of growth hormone therapy.
    Perrini S; Carreira MC; Conserva A; Laviola L; Giorgino F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):79-84. PubMed ID: 19020393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does growth hormone replacement therapy improve cardiac function?
    Giustina A
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):614-5. PubMed ID: 17667899
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone deficiency after traumatic brain injury in adults: when to test and how to treat?
    Kelestimur F
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():534-9. PubMed ID: 19550389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment.
    Swerdlow AJ
    Growth Horm IGF Res; 2000 Dec; 10(6):318-23. PubMed ID: 11161962
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone and the risk of malignancy.
    Alter BP
    Pediatr Blood Cancer; 2004 Oct; 43(5):534-5. PubMed ID: 15382267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.